Long-acting injectable drug prevents HIV infections

May 20, 2020

A long-acting antiretroviral drug given as an injection every 2 months powerfully protected uninfected people from HIV in a large-scale study. The study has not been published in a peer-reviewed journal or presented to HIV researchers at a meeting The apparent success offers a potentially easier alternative to taking daily pills of other antiretrovirals, which has proved difficult for many people. Science


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?